Another ICI treated RCC cohort illustrated a trend toward worse survival at higher BMI that did not reach statistical significance, while the same researchers observed improved outcomes with higher BMI in TKI treated patients at the same institution ( 34 ).
← all excerpts
Obesity-driven metabolic reprogramming and immune dysfunction in renal cancer.
1
—
—